During the past decade, Center for Family Planning Research, Magee-Womens Hospital conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Center for Family Planning Research, Magee-Womens Hospital" #1 sponsor was "University of Pittsburgh" with 4 trials, followed by "Sebela Women's Health Inc." with 2 trials sponsored, "Beatrice Chen" with 1 trials sponsored, "Evofem Inc." with 1 trials sponsored and "International Partnership for Microbicides, Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Center for Family Planning Research, Magee-Womens Hospital" #1 collaborator was "Society of Family Planning" with 3 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 2 trials as a collaborator, "Bill and Melinda Gates Foundation" with 1 trials as a collaborator, "MIMR-PHI Institute, Australia" with 1 trials as a collaborator and "Microbicide Trials Network" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Center for Family Planning Research, Magee-Womens Hospital" are "Contraception" (4 trials), "Women at Risk for Pregnancy" (2 trials), "Abortion in First Trimester" (1 trials), "Bleeding" (1 trials) and "Chlamydia" (1 trials). Many other conditions were trialed in "Center for Family Planning Research, Magee-Womens Hospital" in a lesser frequency.

Most popular intervention types in "Center for Family Planning Research, Magee-Womens Hospital" are "Drug" (7 trials), "Behavioral" (1 trials), "Combination Product" (1 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "3% SPL7013 Gel (VivaGel)" (1 trials), "Avicel PH101 (Microcrystalline Cellulose NF) for Compounding" (1 trials), "DMPA exposure" (1 trials), "Depot medroxyprogesterone acetate" (1 trials) and "Dextromethorphan Hydrobromide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Center for Family Planning Research, Magee-Womens Hospital" are 11 trials for "Female" genders.

Currently, there are NaN active trials in "Center for Family Planning Research, Magee-Womens Hospital". 1 are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Center for Family Planning Research, Magee-Womens Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Center for Family Planning Research, Magee-Womens Hospital, 2 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".